Image Posted on Updated on
According to Organovo,” this is a medical research company headquartered in San Diego which designs and develops three-dimensional human tissue. The living 3D printed tissue can be used for testing drugs before giving the drugs to a real person. Organovo uses a proprietary bioprinting platform called NovoGen for 3D printing tissue.
Pharmaceutical companies conventionally perform testing on animals or on cells in Petri-dishes. Both methods of testing are very different from testing on a living person. Therefore several clinical trials fail when tried on the living person even if they were considered successful on animals or cells in petri-dish. Organovo technology bridges this gap by providing 3D tissue models that are much closer to a living person. Pharmaceutical companies can use the 3D tissues developed using this technology for testing.
In 2014 Organovo announced the commercial release of exVive3DTM Human Liver Tissue for preclinical drug discovery testing. In April 2015, Organovo presented results of 3D printing in vitro 3D kidney tissue at the 2015 Experimental Biology conference in Boston. In 2015 L’Oreal signed an agreement with Organovo to produce 3D-printed skin for use in testing cosmetics. The long-term goal of Organovo’s 3D bioprinting technology is to be able to create organs for transplantation.¨